Skip to main content

Christopher Becker, William Leschensky, Paul Bunn, Gail Eckhardt, Eric Rowinsky, Daniel Von Hoff

Premium

Christopher Becker has been promoted to vice president, chemistry at SurroMed, and William Leschensky has been promoted to president, intellectual property, the company said last week.

Becker joined SurroMed as director of chemistry in 2001, after serving as senior director of proteomic technology at Thermo Electron, and previously, as a staff scientist at SRI. He received his PhD in chemistry at UC Berkeley. Leschensky has been director of intellectual property at SurroMed since 2000, and has also been associate general counsel. Before joining SurroMed, he was an associate at the law firm Fish & Neave. He received his MD from the University of Illinois and a law degree from Harvard Law School.


NaPro Biotherapeutics has formed a new oncology scientific advisory board. It has named as chairman Paul Bunn, and as members, Gail Eckhardt, Eric Rowinsky, and Daniel Von Hoff. Bunn is the director of the University of Colorado Cancer Center, and previously served as president of the American Society of Clinical Oncology and chairman of the US Food and Drug Administration’s Oncology Drugs Advisory Committee. Bunn received his MD from Cornell University Medical College.

Eckhardt is a professor of medicine and the director of the developmental therapeutics and GI malignancies programs at the University of Colorado Health Science Center in Denver. She has previously served as associate director of clinical research, cancer therapy and the research center at the Institute for Drug Development in San Antonio, Texas. She received an MD from the University of Texas Medical Branch in Galveston.

Rowinsky is the director of the Institute for Drug Development, Cancer Therapy and Research Center and clinical professor of medicine at the University of Texas Health Science Center at San Antonio. He received his MD from the Vanderbilt School of Medicine.

Von Hoff is a professor, and directs the Arizona Health Sciences Center cancer therapeutics program and translational research at the Translational Genomics Research Institute, and is chief scientific officer for US Oncology.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.